サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：経頭蓋ドップラー超音波検査の世界市場-2023年～2030年
市場調査レポート
商品コード
1345373

経頭蓋ドップラー超音波検査の世界市場-2023年～2030年

Global Transcranial Doppler Ultrasound Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
経頭蓋ドップラー超音波検査の世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

経頭蓋ドップラー超音波検査の世界市場は、2022年に2,730万米ドルに達し、2030年には4,300万米ドルに達すると予測され、予測期間2023年～2030年のCAGRは6.7%で成長する見込みです。経頭蓋ドップラー超音波検査は、血栓、血管の狭窄部、くも膜下出血による血管攣縮、微小な血栓によって引き起こされる脳卒中を検出します。音波を使って脳の血流に影響を及ぼす医学的問題を検出する、痛みのない検査です。

さらに、疾患の有病率の増加は、経頭蓋ドップラー超音波検査の市場規模を上昇させることができます。米国やカナダのような国におけるヘルスケア拡大家具の増加により、市場は北米地域で需要の増加を経験しています。Viasonix、Rimed、Dawei Medicalなどのその他の主要企業が市場で積極的に活動しています。

市場力学

鎌状赤血球症患者数の増加が市場成長を高める

鎌状赤血球疾患の増加は市場成長を高める可能性があります。例えば、鎌状赤血球症（SCD）は、約10万人の米国人が罹患しています。SCDは、黒人またはアフリカ系米国人の出生365人に1人の割合で発症します。SCDはヒスパニック系米国人の出生16,300人に1人の割合で発症します。黒人またはアフリカ系米国人の赤ちゃんの約13人に1人が鎌状赤血球形質（SCT）を持って生まれます。

さらに、経頭蓋ドップラー超音波検査は、ある種の鎌状赤血球症の子供には必須の検査です。脳卒中は、鎌状赤血球症（SCD）に罹患した小児における最も重篤な合併症のひとつであり、小児の約5～10％が罹患し、発症のピークは生後10年です。この検査は、小児の脳卒中リスクを判定するのに役立ちます。したがって、鎌状赤血球疾患の増加は市場の成長を高める可能性があります。

虚血性脳卒中の有病率の増加は市場成長を加速する可能性がある

虚血性脳卒中の有病率の増加は、市場の成長を加速させる可能性があります。例えば、米国では毎年79万人以上が脳卒中に罹患しています。このうち約61万人が初発または新規の脳卒中です。約18万5,000人の脳卒中は、ほぼ4人に1人が脳卒中既往者です。脳卒中全体の約87％は虚血性脳卒中であり、脳への血流が遮断されます。

血栓、血管の狭窄部、くも膜下出血による血管攣縮、微小な血栓などによる脳卒中を発見することができます。経頭蓋ドップラー（TCD）は急性虚血性脳卒中の診断に最も有用なツールの一つです。微小塞栓、脳血管狭窄の程度、側副血行路に関する貴重な情報が得られます。したがって、虚血性脳卒中の有病率の増加は、市場の成長を高める可能性があります。

TCDに関連する限界は市場成長を妨げる可能性がある

TCDに関連する限界は、頭蓋穹窿内の正しい動脈を挿入するための技術的課題です。また、高齢者（急性脳卒中患者の12～19％）では、厚い頭蓋骨を通して超音波エネルギーが減衰するため、ドップラー波形を得ることが困難な場合があります。フレームレートが遅いと情報が平均化されるため、動きの遅い軟部組織の信号はフラッシュアーチファクトとして現れます。このように、TCDに関連する限界は市場の成長を妨げる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 鎌状赤血球症の増加
      • 虚血性脳卒中の有病率の上昇
    • 抑制要因
      • TCDに伴う限界
    • 機会
      • 診断機器の進歩
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 タイプ別

  • 非二重TCD
  • 二重TCD

第8章 技術別

  • 連続波ドップラー
  • パルス波ドップラー

第9章 用途別

  • 鎌状赤血球症
  • 急性虚血性脳卒中
  • 頭蓋内狭窄閉塞性疾患
  • 血管攣縮
  • その他

第10章 エンドユーザー別

  • 病院
  • 診断検査室
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Viasonix
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な動向
  • Rimed
  • Dawei Medical
  • Konica Minolta Healthcare India Pvt. Ltd.
  • NovoSignal Corp
  • Viasonix
  • Compumedics Germany GmbH
  • RIMED
  • Elekta AB,
  • Shenzhen Delica Medical Equipment Co., Ltd.

第14章 付録

目次
Product Code: MI6737

Market Overview

The Global Transcranial Doppler Ultrasound Market reachedUS$ 27.3 million in 2022 and is expected to reach US$ 43.0 million by 2030, growing with a CAGR of 6.7% during the forecast period 2023-2030. Transcranial doppler ultrasound test detects stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, and tiny blood clots. It is a painless test that uses sound waves to detect medical problems that affect blood flow in the brain.

Furthermore, the increase in the prevalence of the diseases can elevate the transcranial doppler ultrasound market size. Due to the increase in healthcare expanditure in the countries like the U.S. and Canada, the market is experiencing an increase in demand in North American region. Significant key players like Viasonix, Rimed, Dawei Medical, and others are actively operating in the market.

Market Dynamics

Increase in the Number of Sickle Cell Diseases can Elevate the Market Growth

An increase in the number of sickle cell disorders can elevate the market growth. For instance, sickle cell diseases (SCD) affects approximately 100,000 Americans. SCD occurs among about 1 out of every 365 black or African-American births. SCD occurs among about 1 out of every 16,300 hispanic-American births. About 1 in 13 black or African-American babies is born with sickle cell trait (SCT).

Additionally, transcranial doppler ultrasound is an essential test for children with certain type of sickle cell disease. Stroke is one of the most severe complications in children suffering from sickle cell disease (SCD), affecting approximately 5-10% of children with an incidence peak in the first decade of life. This test can help determine the child's risk for stroke. Thus, an increase in the number of sickle cell diseases can elevate market growth.

Rise in the Prevalence of Ischemic Strokes can Accelerate Market Growth

The increase in the prevalence of ischemic strokes can elevate market growth. For instance, every year, more than 790,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes-nearly 1 in 4-are in people with a previous stroke. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.

It can detect stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, tiny blood clots, and more. Transcranial doppler (TCD) is one of the most useful tools in diagnosing acute ischemic stroke. It provides valuable information about microemboli, the degree of cerebral vessel stenosis, and collateral flow. Thus, an increase in the prevalence of ischemic strokes can raise market growth.

Limitations associated with the TCDs can HamperMarket Growth

The limitations associated with the TCDs are technical challenges to insonate the correct artery within the cranial vault. It may also be difficult to obtain doppler waveforms in elderly patients because of the attenuation of ultrasound energy through a thick skull typical in such patients (12-19% of patients with acute stroke). Because of more averaging of information at slower frame rates, slow-moving soft tissue signals appear as flash artifacts. Thus, the limitations associated with TCDs can hamper market growth.

Segment Analysis

The global transcranial doppler ultrasound market is segmented based on type, technology, application, end-user and region.

The Pulsed Wave Doppler Segment Accounted for Approximately 39.8% of the Transcranial Doppler Ultrasound Market Share.

The increase in the advancements of the products can expand the growth of the segment. For instance, on February 9, 2022, Royal Philips announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on the company's Lumify handheld point-of-care ultrasound device. The pulsed wave doppler (PW Doppler) sends short pulses of ultrasound and analyzes reflected sound waves between the pulses.

By sending short and quick pulses of sound, it accurately measures the velocity of blood in a precise location and in real time. The crystals alternate rapidly between sending and analyzing ultrasound. Thus, an increase in the advancements in the products is driving the growth of the segment.

Geographical Penetration

North America Accounted for Approximately 47.2% of the Market Share in 2022.

North America is expected to hold a significant position in the transcranial doppler ultrasound market share. Due to the increase in technological advancements, innovations, and launches, there is a growth of the market in this region. For instance, on March 4, 2021, EchoNous, the leading developer of AI-driven, hand-carried ultrasound, announced the addition of both continuous wave (CW) and pulsed wave (PW) doppler capabilities to the Kosmos hardware platform, the company's flagship offering.

This innovation represents an industry first for an ultra-mobile ultrasound product, creating the first "hybrid" point-of-care ultrasound (POCUS) device, offering extensive machine-benchmarked ultrasound imaging and doppler functionality in a hand-carried unit (HCU). Thus, an increase in technological advancements in the products and the launches is driving the growth of the market.

Competitive Landscape

The major global players in the transcranial doppler ultrasound market include Viasonix, Rimed, Dawei Medical, Konica Minolta Healthcare India Pvt. Ltd., NovoSignal Corp, Viasonix, Compumedics Germany GmbH, RIMED, Elekta AB, Shenzhen Delica Medical Equipment Co., Ltd. and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant influence on the transcranial doppler ultrasound market, posing unprecedented challenges to many countries. The delayed launches and innovations have shown a negative impact on the usage of transcranial doppler ultrasound. The reduced number of product approvals has reduced market growth. Thus, COVID-19 has declined the growth of the transcranial doppler ultrasound market.

By Type

  • Non-Duplex TCDs
  • Duplex TCDs

By Technology

  • Continuous wave Doppler
  • Pulsed Wave Doppler

By Application

  • Sickle Cell Disease
  • Acute Ischemic Stroke
  • Intracranial Steno Occlusive Disease
  • Vasospasm
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Others

By Region

  • North America

U.S.

Canada

Mexico

  • Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

  • South America

Brazil

Argentina

Rest of South America

  • Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

  • Middle East and Africa

Key Developments

  • On February 28, 2023, NovaSignal announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA, in order to advance stroke research and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications in the region.
  • On July 13, 2022, Delica is pleased to announce that they have begun serving the US market with the approval of the Transcranial Doppler EMS-9M by the US FDA. Most recent wireless TCD in the world is called EMS-9M. It is a battery-powered, battery-powered system. Both in sedentary and active modes, it can be used for cerebral evaluations as well as investigations of peripheral and microvascular regions.
  • On March 15, 2022, a medical technology and data company specializing in the assessment and management of brain health announced that its NovaGuide Intelligent Ultrasound has been granted a Medical Device Licence by Health Canada. NovaGuide is now available to Canadian healthcare practitioners for use in capturing and monitoring blood flow in the brain in real-time.

Why Purchase the Report?

  • To visualize the global transcranial doppler ultrasound market segmentation based on type, technology, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of transcranial doppler ultrasound market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in Excel consisting of key products of all the major players.

The global transcranial doppler ultrasound market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the Number of Sickle Cell Diseases
      • 4.1.1.2. Rise in the Prevalence of Ischemic Strokes
    • 4.1.2. Restraints
      • 4.1.2.1. Limitations Associated with the TCDs
    • 4.1.3. Opportunity
      • 4.1.3.1. Advancements in the Diagnostic Devices
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Non-Duplex TCDs
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Duplex TCDs

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Continuous wave Doppler
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Pulsed Wave Doppler

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Sickle Cell Disease
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Acute Ischemic Stroke
  • 9.4. Intracranial Steno Occlusive Disease
  • 9.5. Vasospasm
  • 9.6. Others

10. By End-user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.1.2. Market Attractiveness Index, By End-user
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Diagnostic Laboratories
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Viasonix
    • 13.1.1. Company Overview
    • 13.1.2. ProductPortfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Rimed
  • 13.3. Dawei Medical
  • 13.4. Konica Minolta Healthcare India Pvt. Ltd.
  • 13.5. NovoSignal Corp
  • 13.6. Viasonix
  • 13.7. Compumedics Germany GmbH
  • 13.8. RIMED
  • 13.9. Elekta AB,
  • 13.10. Shenzhen Delica Medical Equipment Co., Ltd.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us